ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - FRA:ACT - DE000A2YNT30 - Common Stock
155.8 EUR
-2.8 (-1.77%)
ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. ACT gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, ACT is valued expensive at the moment. With these ratings, ACT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year ACT was profitable.
ACT had a positive operating cash flow in the past year.
Each year in the past 5 years ACT has been profitable.
Of the past 5 years ACT 4 years had a positive operating cash flow.
1.2 Ratios
ACT has a better Return On Assets (10.48%) than 94.12% of its industry peers.
ACT has a better Return On Equity (26.66%) than 98.53% of its industry peers.
The Return On Invested Capital of ACT (13.72%) is better than 94.12% of its industry peers.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 7.01%.
The last Return On Invested Capital (13.72%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROIC | 13.72% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
ACT has a Profit Margin of 10.43%. This is in the better half of the industry: ACT outperforms 79.41% of its industry peers.
ACT's Profit Margin has improved in the last couple of years.
The Operating Margin of ACT (15.34%) is better than 85.29% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 65.74%, ACT belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACT has been reduced compared to a year ago.
2.2 Solvency
ACT has an Altman-Z score of 5.10. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT has a Altman-Z score of 5.10. This is amongst the best in the industry. ACT outperforms 91.18% of its industry peers.
The Debt to FCF ratio of ACT is 1.15, which is an excellent value as it means it would take ACT, only 1.15 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.15, ACT belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that ACT is not too dependend on debt financing.
ACT's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. ACT outperforms 69.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 5.1 |
ROIC/WACC1.91
WACC7.18%
2.3 Liquidity
ACT has a Current Ratio of 2.84. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
ACT has a better Current ratio (2.84) than 82.35% of its industry peers.
ACT has a Quick Ratio of 1.73. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
ACT has a better Quick ratio (1.73) than 77.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.65%, which is quite impressive.
ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.60% yearly.
The Revenue has been growing slightly by 1.03% in the past year.
Measured over the past years, ACT shows a quite strong growth in Revenue. The Revenue has been growing by 8.06% on average per year.
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
3.2 Future
The Earnings Per Share is expected to grow by 19.37% on average over the next years. This is quite good.
Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 27.29, the valuation of ACT can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
ACT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.08.
Based on the Price/Forward Earnings ratio of 22.72, the valuation of ACT can be described as rather expensive.
ACT's Price/Forward Earnings is on the same level as the industry average.
ACT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.09.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 22.72 |
4.2 Price Multiples
ACT's Enterprise Value to EBITDA is on the same level as the industry average.
ACT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.35 | ||
| EV/EBITDA | 14.33 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ACT may justify a higher PE ratio.
ACT's earnings are expected to grow with 19.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)1.11
EPS Next 2Y16.02%
EPS Next 3Y19.32%
5. Dividend
5.1 Amount
ACT has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
ACT's Dividend Yield is slightly below the industry average, which is at 3.10.
With a Dividend Yield of 1.15, ACT pays less dividend than the S&P500 average, which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
ACT pays out 31.40% of its income as dividend. This is a sustainable payout ratio.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.4%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
FRA:ACT (10/28/2025, 2:35:10 PM)
155.8
-2.8 (-1.77%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners35.95%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap1.59B
Revenue(TTM)555.53M
Net Income(TTM)57.92M
Analysts81.82
Price Target161.52 (3.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP31.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)33.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 22.72 | ||
| P/S | 2.85 | ||
| P/FCF | 38.35 | ||
| P/OCF | 14.09 | ||
| P/B | 7.3 | ||
| P/tB | 7.42 | ||
| EV/EBITDA | 14.33 |
EPS(TTM)5.71
EY3.66%
EPS(NY)6.86
Fwd EY4.4%
FCF(TTM)4.06
FCFY2.61%
OCF(TTM)11.06
OCFY7.1%
SpS54.57
BVpS21.35
TBVpS20.99
PEG (NY)1.56
PEG (5Y)1.11
Graham Number52.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROCE | 19.03% | ||
| ROIC | 13.72% | ||
| ROICexc | 16.02% | ||
| ROICexgc | 16.17% | ||
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% | ||
| FCFM | 7.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 270.53% | ||
| Cap/Sales | 12.82% | ||
| Interest Coverage | 42.05 | ||
| Cash Conversion | 100.91% | ||
| Profit Quality | 71.41% | ||
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 5.1 |
F-Score7
WACC7.18%
ROIC/WACC1.91
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
EBIT growth 1Y19.3%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year49.4%
EBIT Next 3Y27.83%
EBIT Next 5Y19.11%
FCF growth 1Y37.04%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y113.41%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 27.29 and the Price/Book (PB) ratio is 7.3.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.